| Khavinson dipeptide bioregulator studied for immune support. 0.0%7 days | | 0.0% | from$2.25/mg$45.00/vial | 2 in stock | |
| Dual GIP/GLP-1 agonist studied for metabolic health. 0.0%7 days | | 0.0% | from$1.43/mg$34.20/vial | 17 in stock | |
| Zinc-dependent thymic hormone studied for immune and inflammatory signaling. 0.0%7 days | | 0.0% | from$1.80/mg$36.00/vial | 2 in stock | |
| Triple-agonist next-gen GLP-1 research compound. | | 0.6% down | from$1.98/mg$35.99/vial | 27 in stock | |
| Research compound studied for mitochondrial and cognitive effects. 0.0%7 days | | 0.0% | from$0.0097/mg$48.60/bottle | 1 in stock | |
| GLP-1 receptor agonist studied for appetite and weight. 0.0%7 days | | 0.0% | from$3.11/mg$62.10/vial | 4 in stock | |
| Mitochondrial peptide studied for metabolism and endurance. | | 2.0% up | from$1.55/mg$27.00/vial | 17 in stock | |
| Body-protective compound studied for tissue and gut repair. | | 2.4% down | from$1.30/mg$25.19/vial | 13 in stock | |